Internal Medicine, Pulmonary Disease · Philadelphia, PA
NPI
1194836387
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3998 Red Lion Road, Suite 250
Philadelphia, PA, 19114
Phone (215) 612-8500
Groups this clinician bills Medicare through
Medicare paid, 2024
$112K
1,623 services
Medicare patients, 2024
583
Average age 73
Drug cost, 2024
$1.8M
4,272 prescriptions
Company payments, 2025
$38K
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Steven M Geller was code 99214 (office e&m - established), 524 times for 307 patients. In total Steven M Geller billed 1,623 services in 20 codes, and Medicare paid $112K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-01-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 524 | 307 | $96.44 | $51K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 380 | 267 | $12.53 | $4,763 |
| 99232 Hospital E&M - Subsequent | Facility | 297 | 129 | $62.91 | $19K |
| 99213 Office E&M - Established | Office | 130 | 97 | $67.43 | $8,766 |
| 99233 Hospital E&M - Subsequent | Facility | 83 | 53 | $93.47 | $7,758 |
| 99222 Hospital E&M - Initial | Facility | 72 | 71 | $104.31 | $7,510 |
| 99204 Office E&M - New | Office | 67 | 67 | $105.18 | $7,047 |
| 99223 Hospital E&M - Initial | Facility | 30 | 29 | $138.99 | $4,170 |
By year: 2022 $111K for 1,562 services; 2023 $98K for 1,191 services; 2024 $112K for 1,623 services.
Medicare prescription drug claims, 2024
In 2024, the drug Steven M Geller prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 964 prescriptions and refills. In total Steven M Geller wrote 4,272 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 964 | 1,073 | 281 | $29K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 750 | 919 | 152 | $574K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 467 | 539 | 82 | $246K |
| Montelukast Sodium Generic | 253 | 450 | 54 | $2,110 |
| Breo Ellipta Fluticasone/Vilanterol | 222 | 254 | 34 | $98K |
| Prednisone Generic | 217 | 229 | 93 | $699 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 196 | 236 | 36 | $147K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 149 | 187 | 37 | $24K |
| Ventolin Hfa Albuterol Sulfate | 97 | 102 | 23 | $5,651 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 92 | 100 | 16 | $46K |
| Incruse Ellipta Umeclidinium Bromide | 75 | 77 | 11 | $26K |
| Spiriva Respimat Tiotropium Bromide | 72 | 88 | 13 | $44K |
| Fluticasone Propionate Generic | 67 | 125 | 30 | $1,484 |
| Symbicort Budesonide/Formoterol Fumarate | 67 | 83 | 21 | $18K |
| Bevespi Aerosphere Glycopyrrolate/Formoterol Fum | 52 | 54 | 11 | $22K |
Brand drugs: 2,986 claims; generic drugs: 1,286 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Steven M Geller $38K ($38K in general payments such as food, travel and fees) from 23 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $16K.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 50 | $16K |
| Regeneron Healthcare Solutions, Inc. REGN | 15 | $15K |
| GlaxoSmithKline, LLC. GSK | 42 | $4,597 |
| Jazz Pharmaceuticals Inc. JAZZ | 11 | $472 |
| Verona Pharma, Inc. VRNA | 13 | $413 |
| Harmony Biosciences LLC HRMY | 5 | $198 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $195 |
| Genzyme Corporation SNY | 9 | $178 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 6 | $145 |
| Grifols USA, LLC | 4 | $112 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.